Published in Antivir Ther on March 01, 2002
The TREAT Asia HIV Observational Database: baseline and retrospective data. J Acquir Immune Defic Syndr (2005) 3.18
Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis (2004) 2.70
The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal. Retrovirology (2008) 1.38
Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009. J Acquir Immune Defic Syndr (2014) 0.96
New approaches in the treatment of HIV/AIDS - focus on maraviroc and other CCR5 antagonists. Ther Clin Risk Manag (2008) 0.91
Synthesis and anti-HIV activity of (-)-beta-D-(2R,4R)-1,3-dioxolane-2,6-diamino purine (DAPD) (amdoxovir) and (-)-beta-D-(2R,4R)-1,3-dioxolane guanosine (DXG) prodrugs. Antiviral Res (2007) 0.81
The Incidence Rates and Standardized Incidence Ratios of Cancer in Hemophilic HIV/AIDS Patients in Taiwan. J Acquir Immune Defic Syndr (2016) 0.75
Synthesis and antiviral evaluation of 2-amino-6-carbamoylpurine dioxolane nucleoside derivatives and their phosphoramidates prodrugs. Bioorg Med Chem (2014) 0.75
Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era. J Korean Med Sci (2017) 0.75
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet (2001) 9.75
Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet (2003) 7.94
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA (2000) 7.81
Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71
Sexual behaviour in Britain: early heterosexual experience. Lancet (2001) 7.62
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet (1998) 7.53
Meta-analysis: principles and procedures. BMJ (1997) 6.87
Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62
Measuring sexual behaviour: methodological challenges in survey research. Sex Transm Infect (2001) 6.21
Chloroplast transformation in Chlamydomonas with high velocity microprojectiles. Science (1988) 5.91
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (2000) 5.49
Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey. BMJ (1997) 5.29
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet (1999) 4.83
Confounding in epidemiological studies: why "independent" effects may not be all they seem. BMJ (1992) 4.79
Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study. BMJ (2000) 4.51
Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet (1992) 4.42
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel. JAMA (1998) 4.42
Interleukin-2 therapy in patients with HIV infection. N Engl J Med (2009) 4.38
Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet (1996) 4.22
Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis (1999) 4.18
Human C'3: evidence for the liver as the primary site of synthesis. Science (1969) 4.17
Benzothiadiazole induces disease resistance in Arabidopsis by activation of the systemic acquired resistance signal transduction pathway. Plant J (1996) 4.10
From exceptionalism to normalisation: a reappraisal of attitudes and practice around HIV testing. BMJ (1998) 4.09
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
Benzothiadiazole, a novel class of inducers of systemic acquired resistance, activates gene expression and disease resistance in wheat. Plant Cell (1996) 3.98
Smoking as "independent" risk factor for suicide: illustration of an artifact from observational epidemiology? Lancet (1992) 3.92
Pupil-led sex education in England (RIPPLE study): cluster-randomised intervention trial. Lancet (2004) 3.86
Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis (1997) 3.86
Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J (Clin Res Ed) (1986) 3.76
Brief report: disseminated osteomyelitis from Mycobacterium ulcerans after a snakebite. N Engl J Med (1993) 3.75
Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ (1994) 3.71
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med (2008) 3.68
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS (1999) 3.67
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34
Controlling genital chlamydial infection. BMJ (1996) 3.29
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med (1998) 3.24
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet (2003) 3.23
Sexual lifestyles under scrutiny. Nature (1990) 3.19
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA (2001) 2.95
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS (2002) 2.90
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 2.89
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet (1999) 2.80
Passive smoking and health: should we believe Philip Morris's "experts"? BMJ (1996) 2.76
Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis (1987) 2.71
Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 2.70
Risk behaviours for HIV infection among injecting drug users attending a drug dependency clinic. BMJ (1989) 2.68
A scoring system to identify men at high risk of a heart attack. Health Trends (1987) 2.58
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. JAMA (1994) 2.56
The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus: costs of care and prevention in an inner London district. Br Med J (Clin Res Ed) (1986) 2.54
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. J Infect Dis (2001) 2.50
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Arch Intern Med (2000) 2.49
Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease. BMJ (1989) 2.47
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
Active surveillance of sexual behaviour among homosexual men in London. Commun Dis Public Health (1998) 2.45
Risk factors for stroke in middle aged British men. BMJ (1991) 2.44
An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet (2003) 2.43
Rolling out antiretrovirals in Africa: there are still challenges ahead. Clin Infect Dis (2005) 2.43
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS (2001) 2.42
Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood. Lancet (1992) 2.40
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study. HIV Med (2006) 2.38
Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study Group. Arch Intern Med (1998) 2.38
Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med (1992) 2.34
16S rRNA sequence diversity in Mycobacterium celatum strains caused by presence of two different copies of 16S rRNA gene. J Clin Microbiol (1998) 2.33
A cognitive behavioural intervention to reduce sexually transmitted infections among gay men: randomised trial. BMJ (2001) 2.30
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol (1992) 2.27
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? J Infect Dis (2004) 2.26
Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med (2008) 2.26
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis (2001) 2.24
Inflation in epidemiology: "the proof and measurement of association between two things" revisited. BMJ (1996) 2.24
Factors affecting survival in patients with the acquired immunodeficiency syndrome. AIDS (1996) 2.22
Provision of sex education and early sexual experience: the relation examined. BMJ (1995) 2.21
Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis (2001) 2.19
Attitudes to tracing and notifying contacts of people with HIV infection. BMJ (1992) 2.19
HIV testing in developing countries. Lancet (1997) 2.19
A preliminary study of the transmission dynamics of the human immunodeficiency virus (HIV), the causative agent of AIDS. IMA J Math Appl Med Biol (1986) 2.18
Two different 16S rRNA genes in a mycobacterial strain. J Clin Microbiol (1996) 2.17
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med (1999) 2.17
Preliminary report: accurate assays for anti-HIV in urine. Lancet (1990) 2.17
A cohort study of drug users' compliance with zidovudine treatment. Arch Intern Med (1994) 2.16